Skip to main content
. Author manuscript; available in PMC: 2013 Sep 22.
Published in final edited form as: Anesth Analg. 2009 Dec;109(6):1943–1948. doi: 10.1213/ANE.0b013e3181beeb3b

Table 1.

Effect of Treatments on Physiologic Variables

NTG
NTG + NIMO
NIMO
Dependent variables Baseline 5-h average Baseline 5-h average Baseline 5-h average
MAP (mm Hg) 85.9 ± 3.8 31.6 ± 0.8* 86.2 ± 3.7 32.6 ± 0.2* 88.1 ± 3.8 80.0 ± 2.9
% change from baseline 36.8 ± 0.9* 37.8 ± 0.9* 90.7 ± 3.3
PInd, % change from baseline 100 30.4 ± 5.0* 100 31.6 ± 0.8* 100 89.8 ± 5.3
PbtO2 (mm Hg) 51.7 ± 4.5 33.8 ± 5.2 38.6 ± 6.1 25.4 ± 2.0 24.3 ± 4.8 23.2 ± 2.3
% change from baseline 65.3 ± 9.1 65.9 ± 5.3 95.2 ± 9.4
O2 saturation 99.0 ± 0.1 98.2 ± 0.1 98.9 ± 0.2 97.8 ± 0.7 98.5 ± 0.3 98.7 ± 0.1
HR (bpm) 463.7 ± 12.3 465.8 ± 7.2 424.0 ± 10.3 360.8 ± 17.9 431.7 ± 10.2 398.0 ± 8.5

All data are presented as mean ± sem. Change in mean arterial blood pressure (MAP) and perfusion index (PInd) is significantly larger in animals treated with nitroglycerin (NTG) or NTG + nimodipine (NIMO) than in the NIMO group (Mann-Whitney test).

PbtO2 = brain tissue oxygenation; HR = heart rate.

*

Statistical significance (P < 0.05).